- Everyday Alpha
- Posts
- It Beat, It Raised, And It Sold Off Anyway. Here Is What You Do With That
It Beat, It Raised, And It Sold Off Anyway. Here Is What You Do With That
It beat, raised its full-year guide, and the stock still fell 4%. That gap is your opening.
Institutions bought 37,301 calls on this off-price retailer Tuesday, the company beat plan on Wednesday morning, and the shares closed down 4.2% anyway.
The flow read the quarter correctly and the market punished one cautious quarter of guidance instead, which leaves you buying a raised full-year outlook at a 15% discount to the highs.

Standout Picks Now (Sponsored)
Every market cycle produces a handful of companies that dramatically outperform the rest.
Our latest screening has identified the 5 Stocks Set to Double — companies showing rare early-stage momentum traits.
These picks carry the same indicators that historically precede strong rallies.
Past reports highlighted stocks that surged +175%, +498%, and +673%.
Get the Free 5 Stocks Set to Double Report.
*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.

The TJX Companies

August 20 – Pre‑market
Ticker: TJX | Sector: Consumer Cyclical (Off-Price Retail) | Market Cap: $155.42B

30‑Second Take
Why now? TJX reported second-quarter FY27 results before the bell on Wednesday and the quarter came in above plan. Net sales of $15.18 billion, up 5% from $14.40 billion. Comparable sales up 4%, and up 5% across the first half. Diluted EPS of $1.36, up 24% from $1.10 a year ago.
Strip out the $0.14 net benefit from tariff refunds, and adjusted EPS was $1.22, still up 11%. That is the number to anchor on.
Management then raised the full-year FY27 outlook: diluted EPS of $5.31 to $5.36, adjusted EPS of $5.15 to $5.20, and pretax margin of 12.3% to 12.4%.
The stock closed at $140.69, down 8.8% YTD. The reason is one line in the guide. Third-quarter adjusted EPS of $1.30 to $1.32 sits below the roughly $1.35 the Street was carrying, with comps planned up 2% to 3%.
So the business beat on sales, margin, and earnings; the full year went up, and the share price went down on a single quarter of conservative guidance. The 37,301 call contracts bought Tuesday, 437% above the ~6,950 daily average, read the quarter right.

Trade Setup
Timeframe: 4 to 12 weeks
Edge type: Post-earnings dislocation + consumer trade-down
The setup changed shape the moment the print landed. You are no longer paying for an unknown quarter. You know comps ran 4%, you know the full-year guide went up, and you know the only soft spot is one quarter of EPS guidance from a management team with a long history of setting the bar low.

Tax Strategy (Sponsored)
Capital gains taxes can take a bigger bite out of your profits than expected.
Fortunately, some deductions may help reduce the impact — including:
Investment-related expenses
Cost basis adjustments
Certain real estate selling costs
Because rules and eligibility vary, many investors turn to fiduciary financial advisors for guidance.
Find an Advisor Match.


Snapshot Table
Metric | Value | Current Stance |
|---|---|---|
Price | $140.69 | Post-earnings dip on a soft Q3 guide |
52-Week Range | $134.75 - $170.00 | Room to reclaim highs |
Market Cap | ~$155.42B | Large-cap, deep liquidity |
P/E Ratio | 26.02 (TTM) | Premium multiple for the group |
Beta | 0.62 | Low volatility vs. Market |
Avg Daily Volume | 5,629,798 | Deep, liquid name |

Chart

1-Month Trading Summary: TJX has been under pressure for most of the past month, sliding roughly 7% over the 30-day period as retail wobbled on tariff and consumer-spending fears. Wednesday's 4.2% post-earnings drop to $144.50 added to it.
The stock now sits about 15% below its 52-week high of $170.00 and only about $10 above its 52-week low of $134.75.
That gap is your setup. You are buying a raised full-year forecast at a price that was set by one cautious quarter of guidance.

Bull Case
Core thesis: The consumer trade-down is real, and it just showed up in the numbers.
Target lifted its full-year guide this week, and TJX posted 4% comps on top of a 5% first half. Both point to a shopper who is still spending but hunting aggressively for value, and that is the exact tailwind TJX rides. When households pull back at the department stores, they trade down into T.J. Maxx, Marshalls, HomeGoods and Sierra. All four are TJX brands, and this pattern has held for 30 years.
Catalysts: Management raised full-year EPS and pretax margin guidance, and told the market it plans to accelerate store growth beginning in FY28. Companies do not add square footage into demand they do not believe in.
The structural story is intact too. TJX compounds revenue and earnings at high-single to low-double-digit rates, throws off serious cash, and keeps buying back its own stock.
What stands out most: this is a defensive growth name that just beat and raised, trading 15% off its high because one quarter of guidance came in $0.03 light.

Bear Case
Guidance risk is real, not imaginary. Q3 adjusted EPS of $1.30 to $1.32 against a ~$1.35 consensus tells you the back half is not going to be a straight line. If Q3 lands at the low end, you get another leg down, and the stock has already broken its uptrend. Size accordingly and do not put on more than you would be comfortable eating a 5% to 7% move on.
Quality of earnings deserves a look too. The headline $1.36 included a $0.14 net benefit from tariff refunds. That is not recurring. Underlying growth was 11%, which is good, not spectacular, and tariff policy can just as easily run the other way on a business that sources inventory internationally.
Third: valuation is not cheap. At $144.50 against TTM EPS of $5.14, you are paying about 28 times trailing earnings, and about 28 times the adjusted FY27 midpoint. You are buying a compounder at a compounder multiple, not a bargain.

Quick Checklist
✅ Q2 beat confirmed: sales $15.18B up 5%, comps up 4%, diluted EPS $1.36 up 24%
✅ Full-year FY27 guidance raised to $5.31 to $5.36 diluted ($5.15 to $5.20 adjusted)
⚠️ Q3 adjusted EPS guide of $1.30 to $1.32 sits under the ~$1.35 consensus
✅ Next catalyst dated: Q3 FY27 earnings on November 18, 2026

Deep‑Dive Links

That’s all for today’s Everyday Alpha. We’ll have a new pick for you every morning before the market opens, so stay tuned!
Best Regards,
—Noah Zelvis
Everyday Alpha

